http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103157111-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5fdb123bea635f522746d59b87354b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3333b346a6a1d49d19d6f6de8263933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8a334cbee6295be93c268f1a754684
publicationDate 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103157111-B
titleOfInvention New combinaition and pharmaceutical compositions containing same
abstract The invention relates to combination between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}-benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, and an NMDA glutamatergic receptor antagonist.
priorityDate 2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID854026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70941112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452720596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12196675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID907504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428318753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425154543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 49.